Dispensary Cannabidiol (CBD): Nothing to Worry About!
Abstract Introduction: Despite US FDA approval of cannabidiol (CBD) liquid (Epidiolex®), patients with epilepsy still supplement prescription treatments with dispensary…
Abstract Introduction: Despite US FDA approval of cannabidiol (CBD) liquid (Epidiolex®), patients with epilepsy still supplement prescription treatments with dispensary…
Abstract Due to its anticonvulsant properties, cannabidiol can be supportive as an adjuvant therapy in the management of drug resistant…
Abstract Methods: Using data from published alcohol dependence genome-wide association studies, we first conducted a proteome-wide association study of alcohol…
Abstract OBJECTIVE: The objective of this systematic review with meta-analysis was to evaluate the efficacy, safety, and short- and long-term…
Abstract Epilepsy is a disabling, chronic brain disease,affecting ~1% of the World’s population, characterized by recurrent seizures (sudden, uncontrolled brain…
Abstract Seizures are the most common neurological disorders in newborns. Managing neonatal seizures is challenging, especially for neurologists who are…
Abstract In spite of use of cannabidiol (CBD), a non-psychoactive cannabinoid, in pediatric patients with epilepsy, preclinical studies on its…
Abstract Supplementary information: The online version contains supplementary material available at 10.1007/s00431-021-04202-z. Article type: Research Article Keywords: Medical cannabis, Cannabidiol,…
Abstract Objective: Unusual clinical course Background: The electroencephalographic (EEG) findings associated with tetrahydrocannabinol (THC) use, particularly in concentrated form, are…
Abstract Cannabinoids and Cannabis-derived compounds have been receiving especial attention in the epilepsy research scenario. Pharmacological modulation of endocannabinoid system’s…